Citadel Advisors LLC
- SEC CIK
- 0001423053
- Latest filing
- Sep 1, 2026
STLNW holding history
Starling Oncology, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
STLNW overviewAll 13F holders of STLNWFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −12,383−100.0% | Sold out | Holders |
| Q4 2024 | 12,383 | $87 | <0.1% | −5,425−30.5% | Reduced | Holders |
| Q3 2024 | 17,808 | $356 | <0.1% | −100−0.6% | Reduced | Holders |
| Q2 2024 | 17,908 | $364 | <0.1% | +4,534+33.9% | Added | Holders |
| Q1 2024 | 13,374 | $2.94K | <0.1% | −8,831−39.8% | Reduced | Holders |
| Q4 2023 | 22,205 | $2.89K | <0.1% | −10,624−32.4% | Reduced | Holders |
| Q3 2023 | 32,829 | $3.02K | <0.1% | +4,819+17.2% | Added | Holders |
| Q2 2023 | 28,010 | $1.26K | <0.1% | +10,703+61.8% | Added | Holders |
| Q1 2023 | 17,307 | $1.64K | <0.1% | +17,307 | New | Holders |